Specifications
Brand Name :
Aichek
Model Number :
COVID-19-G02001A
Certification :
CE
Place of Origin :
China
MOQ :
5000 Test
Price :
1.2 USD
Payment Terms :
T/T
Supply Ability :
negotiable
Packaging Details :
40box/carton
Storage :
2℃-30℃
User :
Everyone
Accuracy :
99.05% (95% CI: 97.58%~99.63%)
Certificate :
CE ISO 13485
Key words :
Safe Reliable Economic
OEM :
OEM customized packing avaliable
Formats :
25T/box 1T/box
Sample :
Blood
Description

2019-nCov neutralizing Antibody Rapid Test Kit double check for successful vaccination

For professional and in vitro diagnostic use only.

Product Name 2019-nCov neutralizing Antibody Rapid Test Kit
Formats Strip(3mm)Device(4mm) uncut sheet
Place of Origen China
Specimen Blood
Read Time 15 minutes
Shelf life 2 years
Package uncut sheet
Storage 2℃-30℃

For professional and in vitro diagnostic use only.

[INTENDED USE]

The product is suitable for qualitative detection of neutralizing antibodies (NAbs) against SARS-CoV-2 that block the interaction between the receptor binding domain (RBD) of the spike glycoprotein and the Angiotensin converting enzyme Ⅱ (ACE2) receptor. The device can be instrumental in vaccine and therapeutic development as it is suitable for all antibody isotypes. It may also help in current COVID-19 investigations of sero-prevalence, assessment of human immunity, longevity of protective immunity, efficacy of different vaccine candidates as well as tracking infection.

[PERFORMANCE CHARACTERISTICS]

Sensitivity

The sensitivity to S-mIgG1 neutralizing antibody can reach 2ug/mL.

Accuracy

A side-by-side comparison was conducted by the results of SARS-Cov-2 Neutralizing Antibody Test Device (Test Reagent) developed by Hangzhou Deangel Biological Engineering Co., Ltd. and cPassTM from Genscript CO., Ltd. 328 clinical specimens from Professional Point of Care site were evaluated, 105 were positive and others negative. Base on the results from the clinical studies, the statistical analysis was made as follows:

cPassTM Total
Positive Negative

Test

reagent

Positive 96 2 98
Negative 9 221 230
Total 105 223 328

For test reagent, the clinical sensitivity with the “Compared Reagent” was 91.4% (95% CI: 77.7%~100%), the clinical specificity was 99.1% (95% CI: 97.2%~100%), the coincidence rate was 96.6% (95% CI: 92.4%~100%).

[SUMMARY]

The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

2019-NCov Neutralizing Antibody Rapid Test Kit Double Check

2019-NCov Neutralizing Antibody Rapid Test Kit Double Check

Send your message to this supplier
Send Now

2019-NCov Neutralizing Antibody Rapid Test Kit Double Check

Ask Latest Price
Brand Name :
Aichek
Model Number :
COVID-19-G02001A
Certification :
CE
Place of Origin :
China
MOQ :
5000 Test
Price :
1.2 USD
Contact Supplier
2019-NCov Neutralizing Antibody Rapid Test Kit Double Check

Hangzhou Aichek Medical Technology Co.,Ltd

Active Member
4 Years
zhejiang, hangzhou
Since 2012
Business Type :
Manufacturer
Total Annual :
500000-1000000
Employee Number :
150~200
Certification Level :
Active Member
Contact Supplier
Submit Requirement